Each stock in this article is trading near its 52-week high. These elevated prices usually indicate some degree of investor confidence, business improvements, or favorable market conditions.
However, not all companies with momentum are long-term winners, and many investors have lost money by following short-term trends. On that note, here are three overhyped stocks that may correct and some you should consider instead.
Expeditors (EXPD)
One-Month Return: +5.1%
Expeditors (NYSE: EXPD) offers air and ocean freight as well as brokerage services.
Why Are We Cautious About EXPD?
- Flat sales over the last five years suggest it must find different ways to grow during this cycle
- High input costs result in an inferior gross margin of 13.5% that must be offset through higher volumes
- Waning returns on capital imply its previous profit engines are losing steam
Expeditors is trading at $198.65 per share, or 24.8x forward P/E. Check out our free in-depth research report to learn more about why EXPD doesn’t pass our bar.
Gilead Sciences (GILD)
One-Month Return: +6.7%
From its groundbreaking work in developing the first single-tablet regimens for HIV treatment, Gilead Sciences (NASDAQ: GILD) develops and markets innovative medicines for life-threatening diseases including HIV, viral hepatitis, COVID-19, and cancer.
Why Does GILD Worry Us?
- Annual sales growth of 2.7% over the last five years lagged behind its healthcare peers as its large revenue base made it difficult to generate incremental demand
- Expenses have increased as a percentage of revenue over the last five years as its adjusted operating margin fell by 34.2 percentage points
- Falling earnings per share over the last five years has some investors worried as stock prices ultimately follow EPS over the long term
Gilead Sciences’s stock price of $157.57 implies a valuation ratio of 16.7x forward P/E. To fully understand why you should be careful with GILD, check out our full research report (it’s free).
Berkshire Hathaway (BRK.A)
One-Month Return: +1.2%
Led by legendary investor Warren Buffett since 1965, transforming it from a struggling textile manufacturer into a corporate giant, Berkshire Hathaway (NYSE: BRK.A) is a diversified holding company that owns businesses across insurance, railroads, utilities, manufacturing, retail, and services sectors.
Why Is BRK.A Not Exciting?
- Annual sales growth of 4.2% over the last five years lagged behind its financials peers as its large revenue base made it difficult to generate incremental demand
- Earnings growth underperformed the sector average over the last two years as its EPS grew by just 7% annually
At $789,326 per share, Berkshire Hathaway trades at 23.8x forward P/E. Dive into our free research report to see why there are better opportunities than BRK.A.
Stocks We Like More
ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI is taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.
Our AI system flagged Palantir before it ran 1,662% between October 2022 and February 2026. AppLovin before it ran 753% between February 2024 and February 2026. Nvidia before it ran 1,178% between January 2023 and February 2026. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+271% between June 2020 and June 2025). Find your next big winner with StockStory today.
